Evoltra and hypernatraemia Patient Reports February 13, 2012



Evoltra Side Effects Report #6020634-0
Evoltra side effect was reported by a Physician from UNITED KINGDOM on Dec 17, 2008. Female patient, 68 years of age, was diagnosed with acute leukaemia and was treated with Evoltra. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood creatinine increased, diabetes insipidus What is  diabetes insipidus, disease progression, hypernatraemia. Evoltra dosage: unknown. During the same period patient was treated with DAUNORUBICIN. Patient died on 10/12/2008.

Evoltra Side Effects Report #6084210-6
Evoltra side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 03, 2009. Female patient, 68 years of age, was diagnosed with acute leukaemia and was treated with Evoltra. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood creatinine increased, dehydration, hypernatraemia, hypokalaemia, malignant neoplasm progression. Evoltra dosage: unknown. During the same period patient was treated with DAUNORUBICIN. Patient died on 10/12/2008.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Evoltra